Placebo to match Andecaliximab

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Chronic Obstructive Pulmonary DiseaseUlcerative Colitis

Phase 1

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis

CompletedNCT01831427

Gilead SciencesUlcerative Colitis

Start: 2013-03-28End: 2015-02-06Updated: 2021-02-01

Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02077465

Gilead SciencesChronic Obstructive Pulmonary Disease

Start: 2014-03-11End: 2014-10-27Updated: 2020-09-09